How to buy Johnson & Johnson shares | $144.44

Own Johnson & Johnson shares in just a few minutes.

Fact checked

Johnson & Johnson (JNJ) is a leading drug manufacturers—general business based in the US. It opened the day at $147.48 after a previous close of $144.21. During the day the price has varied from a low of $144.38 to a high of $147.55. The latest price was $144.44 (25 minute delay). Johnson & Johnson is listed on the NYSE and employs 132,200 staff. All prices are listed in US Dollars.

How to buy shares in Johnson & Johnson

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: JNJ in this case.
  5. Research Johnson & Johnson shares. The platform should provide the latest information available.
  6. Buy your Johnson & Johnson shares. It's that simple.

How has Coronavirus impacted Johnson & Johnson's share price?

Since the stock market crash in March caused by coronavirus, Johnson & Johnson's share price has had significant negative movement.

Its last market close was $144.44, which is 3.66% down on its pre-crash value of $149.93 and 32.32% up on the lowest point reached during the March crash when the shares fell as low as $109.16.

If you had bought $1,000 worth of Johnson & Johnson shares at the start of February 2020, those shares would have been worth $740.19 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $961.97.

Johnson & Johnson share price

Use our graph to track the performance of JNJ stocks over time.

Johnson & Johnson shares at a glance

Information last updated 2020-09-23.
Previous close$144.21
Change $0.23
Change % 0.159%
Volume 8,663,057
Information last updated 2020-09-20.
52-week range$109.16 - $157
50-day moving average $149.6276
200-day moving average $144.5329
Wall St. target price$165.06
PE ratio 25.8647
Dividend yield $4.04 (2.75%)
Earnings per share (TTM) $5.684
eToro Free Stocks

Invest in Johnson & Johnson shares with 0% commission

Other fees may apply. Your capital is at risk.

  • Unlimited trades, with no dealing charges or management fees
  • If your trades get copied you can earn extra money
  • Create an account today in a few minutes

Share dealing platform comparison

Table: sorted by promoted deals first
Data indicated here is updated regularly
Name Product Price per trade Frequent trader rate Platform fees Brand description
Zero platform fee
Fineco Bank is good for share traders and investors looking for a complete platform and wide offer. Your first 50 trades are free with Fineco, until 30/09/2020. T&Cs apply. Capital at risk.
0% commission on US shares, and £3 on UK shares
From £5
£0 - £24 per quarter
IG is good for experienced traders, and offers learning resources for beginners, all with wide access to shares, ETFs and funds. Capital at risk.
Hargreaves Lansdown Fund and Share Account
No fees
Hargreaves Lansdown is the UK's number one platform for private investors, with the depth of features you'd expect from an established platform. Capital at risk.
eToro Free Stocks
0% commission, no markup, no ticket fee, no management fee
Withdrawal fee & GDP to USD deposit conversion
Capital at risk. 0% commission but other fees may apply.
Interactive Investor
From £7.99 on the Investor Service Plan
From £7.99 on the Investor Service Plan
No transfer fees or exit fees. £9.99 a month on the Investor Service Plan
Interactive Investor offers everything most investors need. Its flat fees makes it pricey for small portfolios, but cheap for big ones. Capital at risk.

Compare up to 4 providers

Data indicated here is updated regularly
Name Product Minimum deposit Maximum annual fee Price per trade Brand description
Moneyfarm stocks and shares ISA
Hargreaves Lansdown stocks and shares ISA
Hargreaves Lansdown is the UK's biggest wealth manager. It's got everything you'll need, from beginners to experienced investors. Capital at risk.
Interactive Investor stocks and shares ISA
Any lump sum or £25 a month
Interactive Investor offers everything most investors need. Its flat fees makes it pricey for small portfolios, but cheap for big ones. Capital at risk.
Saxo Markets stocks and shares ISA
No minimum deposit requirement
Saxo Markets offers a wide access to a range of stocks, ETFs and funds. Capital at risk.
AJ Bell stocks and shares ISA
AJ Bell is a good all-rounder for people who to choose between shares, funds, ISAs and pensions. Capital at risk.
Fidelity stocks and shares ISA
£1000 or a regular savings plan from £50
Fidelity is another good all-rounder, offering a good package at a decent price. Not suited for trading shares. Capital at risk.
Nutmeg stocks and shares ISA
Nutmeg offers three types of portfolios. Choose the one that goes with your investment style. Capital at risk.

Compare up to 4 providers

Data indicated here is updated regularly
Name Product Minimum investment Choose from Annual fee Brand description
Moneyfarm Pension
£1,500 (initial investment)
7 funds
Moneyfarm has pensions that are matched against your risk appetite, goals and planned retirement date. Capital at risk.
PensionBee Pension
No minimum
7 funds
0.5% - 0.95%
Pension Bee is a newbie in the pension market. It helps consolidate your pension plans into one place. Capital at risk.
Hargreaves Lansdown Pension
£100 or £25 a month
2,500 funds
Hargreaves Lansdown is the UK's biggest wealth manager. It's got three different retirement options. Capital at risk.
Interactive Investor Pension
Any lump sum or £25 a month
Over 3,000 funds
interactive investor is a flat-fee platform, which makes it cost effective for larger portfolios. Capital at risk.
Saxo Markets Pension
Saxo Markets Pension
Over 11,000 funds
No annual fee
Saxo Markets gives flexibility and control over your investment strategy. Capital at risk.
AJ Bell Pension
Over 2,000 funds
AJ Bell has two different pension options, a self managed pension and one that is managed for you. Capital at risk.
Moneybox Pension
3 funds
0.15% - 0.45% charged monthly
Manage your money with an easy-to-use Moneybox app. Capital at risk.

Compare up to 4 providers

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Capital is at risk.

Is it a good time to buy Johnson & Johnson stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Johnson & Johnson price performance over time

Historical closes compared with the last close of $144.44

1 week (2020-09-14) -2.64%
1 month (2020-08-24) -5.07%
3 months (2020-06-24) 3.30%
6 months (2020-03-24) 21.19%
1 year (2019-09-20) 9.72%
2 years (2018-09-21) 1.09%
3 years (2017-09-21) 9.63%
5 years (2015-09-21) 55.10%

Is Johnson & Johnson under- or over-valued?

Valuing Johnson & Johnson stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Johnson & Johnson's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Johnson & Johnson's P/E ratio

Johnson & Johnson's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 26x. In other words, Johnson & Johnson shares trade at around 26x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

However, Johnson & Johnson's P/E ratio is best considered in relation to those of others within the drug manufacturers—general industry or those of similar companies.

Johnson & Johnson's PEG ratio

Johnson & Johnson's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.1851. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Johnson & Johnson's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

However, it's sensible to consider Johnson & Johnson's PEG ratio in relation to those of similar companies.

Johnson & Johnson's EBITDA

Johnson & Johnson's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $27.2 billion (£21.4 billion).

The EBITDA is a measure of a Johnson & Johnson's overall financial performance and is widely used to measure a its profitability.

To put Johnson & Johnson's EBITDA into context you can compare it against that of similar companies.

Johnson & Johnson financials

Revenue TTM $80.5 billion
Operating margin TTM 25.09%
Gross profit TTM $54.6 billion
Return on assets TTM 8.05%
Return on equity TTM 24.54%
Profit margin 18.86%
Book value $23.924
Market capitalisation $404 billion

TTM: trailing 12 months

How to short and sell Johnson & Johnson shares

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "JNJ.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 10.6 million Johnson & Johnson shares held short by investors – that's known as Johnson & Johnson's "short interest". This figure is 14.8% down from 12.4 million last month.

There are a few different ways that this level of interest in shorting Johnson & Johnson shares can be evaluated.

Johnson & Johnson's "short interest ratio" (SIR)

Johnson & Johnson's "short interest ratio" (SIR) is the quantity of Johnson & Johnson shares currently shorted divided by the average quantity of Johnson & Johnson shares traded daily (recently around 5.4 million). Johnson & Johnson's SIR currently stands at 1.96. In other words for every 100,000 Johnson & Johnson shares traded daily on the market, roughly 1960 shares are currently held short.

To gain some more context, you can compare Johnson & Johnson's short interest ratio against those of similar companies.

However Johnson & Johnson's short interest can also be evaluated against the total number of tradable Johnson & Johnson shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Johnson & Johnson's short interest could be expressed as 0.004% of the tradable shares (for every 100,000 tradable Johnson & Johnson shares, roughly 4 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Johnson & Johnson.

Find out more about how you can short Johnson & Johnson stock.

Johnson & Johnson's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Johnson & Johnson.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Johnson & Johnson's total ESG risk score

Total ESG risk: 35.78

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Johnson & Johnson's overall score of 35.78 (as at 08/01/2020) is pretty weak – landing it in it in the 72nd percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Johnson & Johnson is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

To gain some more context, you can compare Johnson & Johnson's total ESG risk score against those of similar companies.

Johnson & Johnson's environmental score

Environmental score: 3.79/100

Johnson & Johnson's environmental score of 3.79 puts it squarely in the 7th percentile of companies rated in the same sector. This could suggest that Johnson & Johnson is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Johnson & Johnson's social score

Social score: 25.14/100

Johnson & Johnson's social score of 25.14 puts it squarely in the 7th percentile of companies rated in the same sector. This could suggest that Johnson & Johnson is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Johnson & Johnson's governance score

Governance score: 15.85/100

Johnson & Johnson's governance score puts it squarely in the 7th percentile of companies rated in the same sector. That could suggest that Johnson & Johnson is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Johnson & Johnson's controversy score

Controversy score: 4/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. A high-profile company, Johnson & Johnson scored a 4 out of 5 for controversy – the second-lowest score possible, reflecting that Johnson & Johnson has a damaged public profile.

Wondering how that compares? Below are the controversy scores of similar companies.

Environmental, social, and governance (ESG) summary

Johnson & Johnson was last rated for ESG on: 2020-08-01.

Total ESG score 35.78
Total ESG percentile 72.34
Environmental score 3.79
Environmental score percentile 7
Social score 25.14
Social score percentile 7
Governance score 15.85
Governance score percentile 7
Level of controversy 4

Johnson & Johnson share dividends


Dividend payout ratio: 67.84% of net profits

Recently Johnson & Johnson has paid out, on average, around 67.84% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.75% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Johnson & Johnson shareholders could enjoy a 2.75% return on their shares, in the form of dividend payments. In Johnson & Johnson's case, that would currently equate to about $4.04 per share.

Johnson & Johnson's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.

Johnson & Johnson's most recent dividend payout was on 8 September 2020. The latest dividend was paid out to all shareholders who bought their shares by 24 August 2020 (the "ex-dividend date").

Johnson & Johnson's dividend payout ratio is perhaps best considered in relation to those of similar companies.

Have Johnson & Johnson's shares ever split?

Johnson & Johnson's shares were split on a 2:1 basis on 13 June 2001. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Johnson & Johnson shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Johnson & Johnson shares which in turn could have impacted Johnson & Johnson's share price.

Johnson & Johnson share price volatility

Over the last 12 months, Johnson & Johnson's shares have ranged in value from as little as $109.16 up to $157. A popular way to gauge a stock's volatility is its "beta".

JNJ.US volatility(beta: 0.68)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Johnson & Johnson's is 0.6817. This would suggest that Johnson & Johnson's shares are less volatile than average (for this exchange).

To put Johnson & Johnson's beta into context you can compare it against those of similar companies.

Johnson & Johnson overview

Johnson & Johnson researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular diseases; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

Frequently asked questions

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site